Skip to main content
Home
Browse by Topic
Issues
Latest Issue
Issue Archive
Special Issues
Web Exclusives
Special Series
Conference Correspondent
ASH 2023 - CLL
Ovarian Cancer Overview
Multimedia
All Videos
Interview with the Innovators
Quick Quiz
Subscribe
Home
Browse by Topic
Issues
Latest Issue
Issue Archive
Special Issues
Web Exclusives
Special Series
Conference Correspondent
ASH 2023 - CLL
Ovarian Cancer Overview
Multimedia
All Videos
Interview with the Innovators
Quick Quiz
Subscribe
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
From the Literature
Web Exclusives
Acalabrutinib Demonstrates Efficacy and Safety in Relapsed CLL
Atezolizumab Shows Durable Response, Tolerability in Urothelial Carcinoma
Read More ›
In the Literature: May 2015
From the Literature
TOP - May 2015, Vol 8, No 2
Anti-CD19 CAR T-Cells Show Promise in B-Cell Cancer
Lenvatinib Prolongs Progression-Free Survival in Advanced Thyroid Cancer
Ruxolitinib More Effective Than Standard Therapy in the Treatment of Polycythemia Vera
Read More ›
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
By
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
From the Literature
Web Exclusives
A Phase 3 Trial Comparing Axitinib and Sorafenib in Advanced Renal-Cell Cancer
Read More ›
